Retrospective Evaluation of the Effectiveness of COVID-19 Control Strategies Implemented by the Victorian Government in Melbourne—A Proposal for a Standardized Approach to Review and Reappraise Control Measures

Author:

Fuss Franz Konstantin1ORCID,Tan Adin Ming12,Weizman Yehuda13ORCID

Affiliation:

1. Chair of Biomechanics, Faculty of Engineering Science, University of Bayreuth, D-95448 Bayreuth, Germany

2. Faculty of Health, Arts and Design, Swinburne University, Melbourne, VIC 3000, Australia

3. Department of Health and Medical Science, School of Health Science, Swinburne University of Technology, Hawthorn, VIC 3122, Australia

Abstract

In evaluating the effectiveness of COVID-19 control measures, we propose a standardized approach to assess the impact of COVID-19 management on flattening the curve by analyzing the case data of Victoria, Australia. Its capital, Melbourne, is considered the most lock-downed city in the world. We used the daily case data from Victoria and their first time derivative and compared the dates when the six lockdowns were imposed with the start and end of the effective period, i.e., the period between the maximum and minimum acceleration. Lockdowns 1, 2 (Level 4 restrictions), 3, and 4 were found to be implemented too late, as they were expected to come into effect at the end or after the effective phase, and they were therefore ineffective. It was determined that Lockdown 2 (Level 3 restrictions) did not initiate the effective phase, and it was therefore ineffective, too. Lockdown 5 was expected to take effect in the second half of the effective phase, but showed no changes in the acceleration curve, and it was therefore also ineffective. Lockdown 6, implemented well before the effective period, did not flatten the curve, and was thus also found to be ineffective. The mask mandate between Lockdown 2 (Level 3 and 4 restrictions) initiated the effective phase (likely along with Lockdown 2, Level 3 restrictions), and was therefore found to effectively flatten the curve. The temporal relationship between the assumed cause (control measure) and the observed effect (flattening of the curve) is thus a crucial parameter for assessing the effect of control measures.

Publisher

MDPI AG

Subject

General Medicine

Reference32 articles.

1. Fuss, F.K., Weizman, Y., and Tan, A.M. (2023). The Difference in Wave Dynamics between SARS-CoV-2 Pre-Omicron and Omicron Variant Waves. COVID, 3.

2. Shergold, P., Broadbent, J., Marshall, I., and Varghese, P. (2023, July 01). Fault Lines—An Independent Review into Australia’s Response to COVID-19, 20 October 2022. Available online: https://www.paulramsayfoundation.org.au/news-resources/fault-lines-an-independent-review-into-australias-response-to-covid-19#:~:text=News-,Fault%20lines%3A%20An%20independent%20review%20into%20Australia’s%20response%20to%20COVID,schools%20should%20have%20remained%20open.

3. Achenza, M., and McLeod, C. (2023, June 26). Qld and Vic Premiers Defend Decisions after Damning Review of Australia’s COVID-19 Response. 20 October 2022. Available online: https://www.news.com.au/finance/economy/damning-review-into-covid-response-reveals-how-government-failed-communities/news-story/961ba6276f9f33eb115209f573d97875.

4. British Medical Association (2023, June 26). The Public Health Response by UK Governments to COVID-19 (BMA COVID Review 4), 7 July 2023. Available online: https://www.bma.org.uk/advice-and-support/covid-19/what-the-bma-is-doing/the-public-health-response-by-uk-governments-to-covid-19.

5. Singaporean Government (2023, June 26). White Paper on Singapore’s Response to COVID-19: Lessons for the Next Pandemic. 8 March 2023, Available online: https://www.gov.sg/article/covid-19-white-paper.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3